Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECAP.L Regulatory News (ECAP)

  • There is currently no data for ECAP

KRAMMER LOAN

22 Oct 2009 07:00

RNS Number : 2070B
Elephant Capital PLC
22 October 2009
 



For Immediate Release

22 October  2009

Elephant Capital plc ("Elephant Capital" or "the Company")

Krammer Loan

In June 2007, Tusk Investments Fund 1 (a wholly owned subsidiary of Elephant Capital plc), acquired 40% of Elephant Capital 1 Limited ("Elephant Capital 1"), a new company set up to acquire 2,258,447 shares of Mahindra Forgings Limited. The remaining 60% is owned by Krammer Holdings Pte., Ltd, Singapore ("Krammer"), to whom Tusk Investments Fund 1 advanced a loan of £3.7 million (the "Krammer Loan") to pay for Krammer's 60% holding in Elephant Capital 1. The loan was secured by Krammer's shares in Elephant Capital 1 (the "Guarantee Shares"). Elephant Capital 1's sole asset is the 2,258,447 shares in Mahindra Forgings Limited. In addition, a personal guarantee from Mr. Puneet Makar was provided at the time the Krammer Loan was advanced. Mr Puneet Makar is the sole beneficial owner of Krammer.

The Krammer Loan was repayable on 28 June 2009 with interest charged annually at a rate of 9%. The interest charge for the year to 28 June 2008 amounting to £340,179 has been paid by Krammer. However, neither the principal amount of £3.7 million nor the interest accrued for the year to 28 June 2009 of £333,690 has been received to date (the interest accrued for the period 1 September 2008 to 28 February 2009 was recorded in the interim accounts as income of £165,474); and accordingly the loan is now in default. The Company's management has been negotiating with Krammer since 28 June 2009 to restructure the loan but no solution has been forthcoming.  

In view of the above, the Board of Elephant Capital believes the best alternative, in the absence of an acceptable solution from Krammer, is to settle the transaction immediately, by assuming control of the Guarantee Shares. As at the year-end date of 31 August 2009, the transaction will result in a write-down for Elephant Capital of up to £2.8 million, including unpaid interest, equating to an NAV reduction of approximately 5.6 pence per share. This mirrors the write-down already taken in respect of the 40% shareholding in Elephant Capital 1.

In addition, the Board of Elephant Capital has notified Mr. Puneet Makar that in the event that the Guarantee Shares are sold, and there is a shortfall on the amount outstanding to the Company, that Elephant Capital would consider invoking the personal guarantee he provided on entering into the loan agreement.

Elephant Capital will update the market as appropriate.

 

For further information please contact:

Gaurav Burman

Elephant Capital plc 

+44 (0) 20 7292 6070

Nandita Sahgal / Tom Sheldon

Seymour Pierce Limited

+44 (0) 20 7107 8000

Mark Edwards / Nicola Cronk

Buchanan Communications

+44 (0) 20 7466 5000

Notes to editors:

Elephant Capital plc

Elephant Capital plc (previously named Promethean India plc) was launched in April 2007 as an AIM listed fund. The fund invests in private and public equity investments in India and is advised by an India-based advisory team. Five investments have been made to date across a range of sectors including Hospitality, Automotive, Education, Building Materials and Mobile Banking Services.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCCKBKNPBDKBKB
Date   Source Headline
5th Mar 20137:00 amRNSChange of Adviser
27th Feb 201310:00 amRNSNotice of Annual General Meeting and Tender Offer
27th Feb 201310:00 amRNSPreliminary Results for the year ended 31 Aug 2012
13th Dec 20122:45 pmRNSSettlement of ClinTec claim
11th Sep 201212:24 pmRNSDisposal of Investment
27th Jun 20127:30 amRNSSuspension - Elephant Capital Plc
27th Jun 20127:30 amRNSSuspension and Cancellation of Warrants
18th Jun 201211:38 amRNSReminder of Subscription Rights
28th May 20127:00 amRNSHalf Yearly Report
23rd Mar 20124:38 pmRNSDirectorate Change
23rd Mar 20129:52 amRNSResult of AGM
28th Feb 201210:04 amRNSPreliminary results
9th Nov 201110:33 amRNSAcquisition
7th Nov 20118:28 amRNSAppointment of Chairman
10th Oct 201111:04 amRNSHolding(s) in Company
16th Sep 20113:12 pmRNSTransaction in Own Shares
22nd Jul 20113:28 pmRNSTender Offer Update
30th Jun 201110:41 amRNSSole Broker Confirmation
28th Jun 201112:49 pmRNSResult of Warrantholders' Meeting
27th Jun 20115:12 pmRNSHolding(s) in Company
21st Jun 20114:07 pmRNSResult of EGM - Tender Offer Update
10th Jun 20111:01 pmRNSHolding(s) in Company
10th Jun 201110:14 amRNSHolding(s) in Company
9th Jun 20112:53 pmRNSHolding(s) in Company
8th Jun 20113:27 pmRNSHolding(s) in Company
27th May 20118:00 amRNSTender Offer
27th May 20117:00 amRNSInterim Results
18th May 20117:00 amRNSELEPHANT CAPITAL INVESTS IN AIR WORKS INDIA
15th Apr 20117:00 amRNSFOLLOW-ON INVESTMENT IN AMAR CHITRA KATHA PVT LTD
12th Apr 20117:00 amRNSEIH LTD ("EIH") RIGHTS ISSUE
28th Feb 20117:31 amRNSPreliminary Results
29th Dec 20107:00 amRNSNAV AND QUARTERLY NEWSLETTER
11th Oct 20107:00 amRNSDirectorate Change
1st Oct 20107:00 amRNSAppointment of Joint Corporate Broker
20th Sep 20107:00 amRNSNAV AND QUARTERLY NEWSLETTER
9th Sep 20107:00 amRNSGLOBAL CRICKET VENTURES ("GCV") MEDIA RIGHTS
20th Aug 20107:00 amRNSDISPOSAL OF INVESTMENT
18th Aug 20107:02 amRNSELEPHANT CAPITAL INVESTS IN CLINTEC LUXEMBOURG S.A
16th Jun 20107:00 amRNSELEPHANT CAPITAL INVESTS IN AMAR CHITRA KATHA PVT.
10th Jun 20107:00 amRNSNAV AND QUARTERLY NEWSLETTER
25th May 20107:00 amRNSInterim Results
24th Mar 201012:24 pmRNSResult of AGM
8th Mar 20107:00 amRNSNAV AND QUARTERLY NEWSLETTER
23rd Feb 20107:00 amRNSPreliminary Results
16th Feb 20107:00 amRNSKrammer Loan Update
16th Feb 20107:00 amRNSPARTIAL DISPOSAL OF INVESTMENT
21st Jan 20107:00 amRNSGCV Investment
21st Jan 20107:00 amRNSGCV Partners Google
22nd Dec 20097:00 amRNSQuarterly Newsletter - November 2009
8th Dec 200911:42 amRNSInvestee Company Award Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.